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In a previous study, we determined that HP(2–20) (residues 2–20 of parental HP derived from the N-terminus of Helicobacter pylori Ribosomal
Protein L1) and its analogue, HPA3, exhibit broad-spectrum antimicrobial activity. The primary objective of the present study was to gain insight into
the relevant mechanisms of action using analogues of HP(2–20) together with model liposomes of various lipid compositions and electron
microscopy. We determined that these analogues, HPA3 and HPA3NT3, exert potent antibacterial effects in low-salt buffer and antifungal activity
against chitin-containing fungi, while having little or no hemolytic activity or cytotoxicity against mammalian cell lines. Our examination of the
interaction of HP(2–20) and its analogues with liposomes showed that the peptides disturb both neutral and negatively-charged membranes, as
demonstrated by the release of encapsulated fluorescent markers. The release of fluorescent markers induced by HP(2–20) and its analogues was
inversely related to marker size. The pore created by HP(2–20) shows that the radius is approximately 1.8 nm, whereas HPA3, HPA3NT3, and
melittin have apparent radii between 3.3 and 4.8 nm. Finally, as shown by electron microscopy, the liposomes and various microbial cells treated with
HPA3 and HPA3NT3 showed oligomerization and blebbing similar to that seen with melittin, while HP(2–20) exhibited flabbiness. These results
suggest that HP(2–20) may exert its antibiotic effects through a small pore (about 1.8 nm), whereas HPA3 and HPA3NT3 formed pores of a size
consistent with those formed by melittin.
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Membrane-active peptides, including a host of antimicrobials
and toxins, have been shown to induce the formation of trans-
membrane pores. Although the molecular mechanisms by which
pore formations occur remain to be thoroughly elucidated, the
three mechanisms thus far proposed include the “barrel-stave”,
“carpet”, and “toroidal” models. In the barrel-stave model,
peptide helices form a bundle with a central lumen within the
membrane, appearing similar to a barrel in which the helical
peptides function as the staves [1–5]. This variety of trans-
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as alamethicin. It was reported that alamethicin produced pores
of ∼1.8 nm and ∼4.0 nm (inner and outer diameter,
respectively) at the threshold concentration of the peptide/
lipid ratio [6,7]. These dimensions imply that the walls of the
channel are ∼1.1 nm in thickness, while is similar to the
diameter of the alamethicin helix. Thus, its pores are consistent
with an arrangement of eight alamethicin monomers in a barrel-
stave configuration [1,8,9].
The carpet model elucidates the activity of antimicrobial
peptides such as ovispirin [10]. In this case, peptides accumulate
on the bilayer surface, oriented in parallel – i.e., in-plane – with
the membrane surface [11,12]. The peptides are electrostatically
attracted to the anionic phospholipid head groups at numerous
sites, and thereby cover the surface of the membrane in a carpet-
like manner [13–17].
In the toroidal-pore model, which has been advanced to
explain the activity of the magainins [18], protegrins [19], and
melittin [1], the polar faces of the peptides associate with the polar
head groups of the lipids and remain in this orientation evenwhen
they are perpendicularly inserted into the lipid bilayer, a feature
which distinguishes it from the barrel-stavemodel. Themagainin-
induced toroidal pores are larger and vary in size to a greater
extent than has been observed with the alamethicin-induced pores
[1]. They evidence an inner diameter of 3.0–5.0 nm and an outer
diameter of ∼ 7.0–8.4 nm, and each of the pores is thought to
harbor 4–7 magainin monomers and∼90 lipid molecules [1,20].
Melittin, magainin, and alamethicin are the prototype peptides
employed in studies of the mechanisms underlying pore
formation in both the toroidal and barrel-stave models [21].
Stomach mucosa that is infected withHelicobacter pylori, the
bacterial pathogen associated with gastritis and peptic ulcers,
typically shows massive infiltration of inflammatory cells and
tissue destruction [22]. Persistence ofH. pylori in the mucosa has
been suggested to be facilitated by H. pylori-produced cecropin-
like peptides with antibacterial properties. Although H. pylori
itself is resistant to this peptide, the release of these peptides gives
a competitive advantage over other microorganisms [23].
The linear antimicrobial peptide, HP(2–20), is a cationic
α-helical peptide that has been isolated from the N-terminal
region of the Helicobacter pylori ribosomal protein, L1 [24].
This peptide possesses several important functional char-
acteristics; it is bactericidal, it is a neutrophil chemoattractant,
and it activates phagocyte NADPH oxidase to produce re-
active oxygen species [24].
The primary objective of the present studywas to characterize
the effects of HP(2–20) and its analogues on a variety of lipid
compositions and cell wall components, and to make observa-
tions via electron microscopy. In addition, we assessed pore
sizes in these zwitterionic vesicles via dextran leakage and
transmission electron microscopy.
2. Materials and methods
2.1. Materials
Proteinase K, trypsin, chitin, cellulose, chitosan, curdlan, peptidoglycan
(from Staphylococcus aureus), LPS (lipopolysaccharide)1 (from Escherichiacoli 0111:B4), BCA protein reagent, BS3 (Bis(sulfosuccinimidyl)suberate), PE
(L-α-phosphatidylethanolamine) (Type V, from E. coli), SM (sphingomyelin,
from bovine brain), CH (cholesterol, from porcine liver), and FITC-D
(fluorescein isothiocyanate dextrans), with average molecular masses of 4, 10,
20, 40, 70, and 500 kDa were all purchased from the Sigma Chemical Co. (St.
Louis, MO). PG (L-α-phosphatidyl-DL-glycerol), PC (egg yolk L-α-phosphati-
dylcholine), PS (phosphatidylserine, from brain) and CL (cardiolipin, from
E. coli) were obtained from Avanti Polar Lipids (Alabaster, AL). DiSC3-5 (3,3′-
diethylthio-dicarbocyanine iodide) and calcein were acquired from Molecular
Probes (Eugene, OR). All other reagents were of analytical grade. Buffers were
prepared in double glass-distilled water.
2.2. Peptide synthesis and purification
All peptides were synthesized via solid-phase methods with Fmoc (N-(9-
fluorenyl)methoxycarbonyl)-protected amino acids on an Applied Biosystems
Model 433A peptide synthesizer. 4-Methyl benzhydrylamine resin (Novabio-
chem) (0.55 mmol/g) was employed to create the amidated C-terminus. For each
coupling step, the Fmoc-protected amino acid and coupling reagents were added
in a 10-fold molar excess with regard to resin concentration. Coupling (60–
90 min) was conducted with DCC (dicyclohexylcarbodiimide) and HOBT (1-
hydroxy benzotriazole) in NMP (N-methyl-2-pyrrolidone). Cleavage from the
resin and the deprotection of the synthesized peptide were conducted using a
solution of 90% trifluoroacetic acid, 3% water, 1% triisopropylsilane and 2%
each of 1,2-ethanedithiol, thioanisole, and phenol. After repeated ether
precipitation, the crude peptide was purified via reversed-phase preparative
HPLC on a Waters 15-μm Deltapak C18 column (19×300 mm) using an
appropriate 0–60% acetonitrile gradient in 0.1% trifluoroacetic acid. The purity
of the purified peptide was then determined via analytical reversed-phase HPLC
using a Vydac C18 column (4.6×250 mm, 300 Å, 5 nm). The molecular masses
of the peptides were verified with a matrix-assisted laser desorption ionization
mass spectrometer (MALDI II, Kratos Analytical Ins.).
2.3. Antimicrobial assay
Candida albicans was cultured at 28 °C in YPD broth. E. coli and S. aureus
were cultured at 37 °C in trypticase soy broth. The antimicrobial activity of each
peptide was determined via microdilution assays. In brief, the microorganisms
were collected in mid-log phase and suspended in buffer I (low ionic strength
buffer; 10 mM sodium phosphate, pH 7.2) or buffer II [high ionic strength
buffer; PBS (1.5 mMKH2PO4, 2.7 mMKCl, 8.1 mMNa2HPO4, 135 mMNaCl,
pH 7.2)]. Two-fold serial dilutions of each of the peptides, in a range from 0.39
to 200 μM, in buffers I and II, were arranged in sterile 96-well plates, after which
aliquots of the cell suspension (1×106 CFU/ml) was added to each well. Plates
containing fungal cells were incubated for 2 h at 28 °C, while the plates
containing the bacterial cells were incubated at 37 °C for the same amount of
time. At the end of the incubation, 50 μl of 20-fold diluted samples were plated
on appropriate agar plates, and were then incubated for 24 h, after which the
colonies were counted. The lowest concentration of peptide that completely
inhibited growth was defined as the MIC. The MIC values were calculated as an
average of several independent experiments conducted in triplicate.
2.4. hRBC (human red blood cell) hemolysis
Hemolytic activities were assessed for all peptides, using hRBCs from healthy
donors, and collected on heparin. The fresh hRBCswere rinsed three times in PBS
via 10 min of centrifugation at 800×g, and resuspended in PBS. The peptides
dissolved in PBS were then added to 100 μl of the stock hRBCs suspended in PBS
(final RBCconcentration, 8%v/v). The sampleswere then incubatedwith agitation
for 60 min at 37 °C, and then centrifuged for 10 min at 800×g. The absorbance of
the supernatants was assessed at 414 nm; the controls for zero hemolysis (blank)
and 100% hemolysis were comprised of hRBCs suspended in PBS and 1% Triton
X-100, respectively. Each measurement was conducted in triplicate.
2.5. Cell line and culture
The human keratinocyte HaCaTcell line was obtained from Dr. NE. Fusenig
(Heidelberg, Germany). Cells, cultured in 75 cm2 plastic flasks, were grown in
231S.-C. Park et al. / Biochimica et Biophysica Acta 1778 (2008) 229–241Dulbecco's modified Eagle medium (DMEM) supplemented with antibiotics
(100 U/mL penicillin, 100 μg/mL streptomycin), 10% fetal calf serum, 1 mM
pyruvate, and 4 mM L-glutamine. The cells were then cultured at 37 °C in a
humidified chamber in an atmosphere containing 5% CO2.
2.6. Cytotoxicity
The percentage of growth inhibition was evaluated using a MTT (Sigma)
assay for the measurement of viable cells. A total of 4×103 cells/well was
seeded onto a 96-well plate for 24 h, treated with various concentrations of the
tested peptides, then incubated for an additional 24 h at 37 °C. Subsequently,
10 μl of MTT at a concentration of 5 mg/ml was added to each of the wells, and
the cells were incubated for an additional 4 h. The supernatants were aspirated
and 100 μl of DMSO were added to the wells in order to dissolve any remaining
precipitate. Absorbance was then measured at a wavelength of 570 nm using an
ELX800 reader (Bio-Tek instruments, Inc., Winooski, VT).
2.7. Peptide binding to microbial cell wall components
In order to determine the in vitro binding of synthetic HP-family peptides
to curdlan (β-1, 3-glucan), peptidoglycan (β-1, 4-glycosidic linkage between
N-acetylmuramic acid and N-acetylglucosamine), chitin (β-1, 4-N-acetyl-D-
glucosamine) and cellulose (β-1, 4-glucan), 200 μg of each insoluble
polysaccharide was added to 200 μl of buffer I or buffer II containing 5 μg
of peptides, then incubated for 1 hour at 20–22 °C with 180 rpm. The mixture
was then centrifuged (12,000×g for 3 min), and the pellet was washed three
times in 0.5 ml of washing buffer (10 mM Tris, pH 7.5, 500 mM NaCl, 0.02%
Tween 20). The peptides bound to the insoluble polysaccharides were detached
via the addition of SDS-PAGE sample buffer, and then subjected to 16.5%
Tricine-SDS-PAGE. LPS binding assays were conducted in essentially the
same manner, except that the binding mixture was centrifuged for 15 min at
22,000×g at each step in order to precipitate small LPS particles.
2.8. Peptide binding to liposomes
An assay to determine the binding of peptides to various lipids was
performed according to the method described by Makino et al. [25], with some
modification. In brief, 50 μl of lipid (250 μM) in chloroform was added to each
well of a polypropylene microtiter plate (Nunc, Roskilde, Denmark). After
evaporation of the solvent at room temperature, the wells were then washed with
buffer (10 mM sodium phosphate, pH 7.2) and incubated with 50 μl of 40 μM
peptide for 2 h at room temperature. The unbound peptide was removed, and the
wells were then washed twice with the same buffer. The concentration of
unbound peptide was measured using a BCA kit (Pierce, Rockford, IL) in order
to compare the intensities of bound peptide on SDS-PAGE. After washing,
Tricine SDS-PAGE buffer was added to each well for the suspension of bound
peptide, and the suspensions were subjected to SDS-PAGE on 16.5% Tricine
gels. The amount of bound peptide was detected according to the intensity of
stained bands as a form of qualitative analysis.
2.9. Calcein release from liposomes
The interaction and permeabilization of peptides against liposomes were
assayed by measuring calcein leakage. Calcein-entrapped liposomes were
prepared for use in dye leakage experiments as follows. In brief, calcein-
entrapped LUVs (large unilamellar vesicles) were prepared by vortexing the
dried lipid in dye buffer solution (70 mM calcein, 10 mM HEPES, 150 mM
NaCl, 0.1 mM EDTA, pH 7.4). The suspension was freeze–thawed in liquid
nitrogen for nine cycles and extruded 30 times through polycarbonate filters
(two stacked 0.2-μm pore size filters) using an Avanti Mini-Extruder (Avanti
Polar Lipids inc., Alabaster, AL). Calcein-entrapped vesicles were separated
from free calcein by gel filtration chromatography on a Sephadex G-50 column.
Entrapped LUVs in suspensions containing 100 μM lipids were incubated with
various concentrations of the peptide (0.6–20 μM). The fluorescence of the
released calcein was assessed with a spectrofluorometer (Perkin-Elmer LS55) at
an excitation wavelength of 480 nm and an emission wavelength of 520 nm.
Complete (100%) release was achieved via the addition of Triton X-100 to afinal concentration of 1 mM. Spontaneous leakage was determined to be
negligible at this time scale. The experiments were conducted at 25 °C. The
apparent percentage of calcein release was calculated in accordance with the
following equation [26]
Release ð%Þ ¼ 100 ðF  F0Þ=ðFt  F0Þ
in which F and Ft represent the fluorescence intensity prior to and after the
addition of the detergent, respectively, and F0 represents the fluorescence of the
intact vesicles.
2.10. Membrane depolarization in bacteria and yeast
Membrane depolarization was assessed using Dis-C3-5, a lipophilic
potentiometric indicator dye.
2.10.1. (i) Gram-positive bacteria
S. aureuswas grown to mid-log phase at 37 °C with agitation. The cells were
washed once in buffer A (20 mM glucose, 5 mM HEPES, pH 7.3) and
resuspended to an OD600 of 0.05 in buffer A containing 0.1 M KCl. The cells
were then incubated with 1 μM DiS-C3-5 until stable baseline fluorescence was
achieved. The experiments were conducted in sterile 96-well plates at a final
volume of 200 μl. The peptides dissolved in buffer A were added in order to
achieve the desired concentration, after which membrane depolarization was
detected as an increase in the DiS-C3-5 fluorescence (excitation wavelength,
622 nm; emission wavelength, 670 nm).
2.10.2. (ii) Intact Gram-negative bacteria
The assay for intact Gram-negative bacteria was conducted using exactly the
same method as described above, except with E. coli ATCC 25922.
2.10.3. (iii) Spheroplasts of Gram-negative bacteria
Spheroplasts of E. coli ATCC 25922 bacteria were prepared via an osmotic
shocktechnique. First, cells from cultures grown to OD600 of 0.8 were harvested
via centrifugation, washed twice in buffer C (10 mM Tris/H2SO4, 25% sucrose,
pH 7.5), and resuspended in buffer C containing 1 mM EDTA. After 10 min of
incubation at 20 °C with rotary mixing, the cells were harvested via
centrifugation, immediately resuspended in freezing (0 °C) water and incubated
for 10 min at 4 °C. The resultant spheroplasts were harvested via centrifugation
and resuspended to an OD600 of 0.05 in buffer D (20mMglucose, 5 mMHEPES,
1 M KCl, pH 7.3). Further treatments were conducted as described for S. aureus.
2.10.4. (iv) Intact yeast
In order to detect membrane depolarization in intact yeast (C. albicans), cells
were incubated at 35 °C to mid-log phase in RPMI 1640 (165 mM MOPS, pH
7.0, with L-glutamine and NaHCO3) with agitation and washed with Ca
2+- and
Mg2+-free PBS, after which the samples (2×105 CFU/ml) were incubated with
1 μMDiS-C3-5 and membrane depolarization was evaluated as described above.
2.11. Preparation of dextran-loaded liposomes and leakage experiments
FITC-labeled dextrans (FD-4, 10, 20, 40, 70 and 500) were utilized as model
cytoplasmic components. FD-entrapping liposomes (unilamellar vesicles) with
different lipid compositions were prepared using the reverse-phase evaporation
method [27], and the concentrations of the FD-entrapped vesicles were
determined in triplicate using a phosphorus assay [28]. To prepare FD-entrapped
liposomes, a buffer solution (buffer II: PBS) containing 2 mg/ml of the FD was
sonicated for 30 min with a lipid solution in chloroform (20 mg/ml) on ice. The
chloroform was then gradually removed using a rotary vacuum evaporator at
25 °C, resulting first in the formation of a viscous gel, and then a liposome
suspension. Buffer (2 ml) was added, and the suspension was evaporated further
for the removal of the remaining solvent. The liposome suspensions were then
centrifuged and washed for several cycles at 22,000×gav for 30 min in order to
remove unentrapped-FD. The washed liposomes were extruded 30 times
through polycarbonate filters (two stacked 0.4-μm pore size filters) using an
Avanti Mini-Extruder (Avanti Polar Lipids inc., Alabaster, AL) to obtain
liposomes of homogeneous size (∼400 nm). Aliquots of the peptide solutions at
appropriate concentrations were incubated with a suspension of FD-loaded
Table 1
Sequence alignment of HP(2–20) and its analogue peptides
Name Sequence Net charge
Original source 2 5 10 15 20
HP (2–20) AKKVFKRLEKLFSKIQNDK +5
Truncated peptides
HPN1(4–20) KVFKRLEKLFSKIQNDK +4
HPN2(6–20) FKRLEKLFSKIQNDK +3
HPN3(8–20) RLEKLFSKIQNDK +2
HPC1(2–18) AKKVFKRLEKLFSKIQN +5
HPC2(2–16) AKKVFKRLEKLFSKI +5
HPC3(2–14) AKKVFKRLEKLFS +4
HPN1C2(4–16) KVFKRLEKLFSKI +4
HPN1C3(4–14) KVFKRLEKLFS +3
HPN2C4(6–13) FKRLEKLF +2
Amino-acid substitution of HP(2–20)
HPA1 AKKVFKRLEKLFSKIQNWK +6
HPA2 AKKVFKRLEKLFSKIWNDK +5
HPA3 AKKVFKRLEKLFSKIWNWK +6
HPA4 AKKVFKRLEKSFSKIQNDK +5
HPA5 AKKVSKRLEKLFSKIQNDK +5
HPA3A1 WKKVFKRLEKLFSKIWNWK +6
Truncation and amino-acid substitution of HPA3
HPA3NT0 FKRLEKLFSKIWNWK +4
HPA3NT1 FKRLKKLFSKIWNWK +6
HPA3NT2 FKRLEKLFKKIWNWK +5
HPA3NT3 FKRLKKLFKKIWNWK +7
Amino-acid substitution of HPC2
HPC2A3 AKKVFKRLRKLFKKI +8
Control peptide
Melittin GIGAVLKVLTTGLPALISWIKRKRQQ +5
Each peptide sequence is labeled with a serial number on the left and the sample
name on the right. Amino acid substitutions are indicated in bold letters.
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30 min at 22,000×g. The supernatants were recovered and their leakages were
recorded by monitoring the fluorescence intensity of FITC (excitation
wavelength: 494 nm, emission wavelength: 520 nm). 100% leakage was
achieved upon the addition of Triton X-100 to a final concentration of 1 mM.
The percent leakage value was then plotted.
2.12. Cross-linking analysis
HP(2–20) or the indicated analogue was initially incubated for 10 min with
PC/cholesterol (10:1, w/w) liposomes at 25 °C, and then for an additional 1 h
with 80 μM BS3. After incubation, the samples were added to tricine sample
buffer and subjected to 16.5% Tricine–SDS-PAGE without heating. The peptide
bands were identified in the gels after Coomassie Brilliant Blue G-250 staining.
2.13. Transmission electron microscopy (TEM)
Small unilamellar vesicles for TEM analysis were prepared as follows. Dry
lipids [PE/PG (7:3, w/w) or PC/cholesterol (10:1, w/w)] were dissolved in
chloroform in a small glass vessel. Solvents were removed by nitrogen gas, so
that they formed a thin film on the wall of a glass vessel and then lyo-
philized overnight. Dried thin films were resuspended in 10 mM sodium
phosphate buffer by vortex mixing. The lipid dispersions were then sonicated in
ice for 10–20 min using a titanium-tip ultrasonicator until the solution became
opalescent.
HP and its analogues were incubated with SUVs (small unilamellar vesicles)
at 25 °C in 10 mM sodium phosphate buffer. After incubation, the peptides were
applied to glow-discharged carbon-coated copper grids for 1 min. The grids
were rinsed in the same buffer, and stained with 2% (w/v) uranyl acetate.
Electron micrographs were then recorded (FEI Technei 12 microscope) at
nominal magnification (×67,000–110,000) with an accelerating voltage of
120 kV.
2.14. Electron microscopic examination of bacterial
and fungal membranes
Midgrowth-phase S. aureus, E. coli, and C. albicans were resuspended at
108C.F.U./ml in sodium-phosphate buffer, at a pH of 7.4, supplemented with
100 mM NaCl, and then incubated at 37 °C and 28 °C, respectively, with HP, its
analogues, and melittin. Controls were run in the absence of peptide solution.
After 30 min, the cells were fixed with an equal volume of 5% (v/v) glutaral-
dehyde in 0.2 M sodium-cacodylate buffer, at a pH of 7.4. After 2 h of fixation at
4 °C, the samples were filtered on isopore filters (0.2 μm pore size, Millipore,
Bedford, MA) and washed extensively with 0.1 M cacodylate buffer, at a pH of
7.4. The filters were then treated with 1% (w/v) osmium tetroxide, washed in 5%
(w/v) sucrose in cacodylate buffer, and subsequently dehydrated with a graded
series of ethanol. After lyophilization and gold coating, the samples were
evaluated on a HITACHI S-2400 instrument (HITACHI, Japan).
2.15. Circular dichroism (CD) analysis in SDS micelles
and PC/CH liposome
CD spectra were recorded at 25 °C on a Jasco 810 spectropolarimeter (Jasco,
MD, USA) equipped with a temperature control unit. A 0.1-cm path-length
quartz cell was used for a 50-μM peptide solution. At least five scans were
averaged for each sample and the averaged blank spectra were subtracted. Each
spectrum was obtained by averaging five scans in the 250–190 nm wavelength
range. All CD spectra are reported in mean residue ellipticity, [θ]MRW, in
deg·cm2dmol-1. The α-helical content was determined from the mean residue
ellipticities at 222 nm, as indicated in Equation (1) [29].
% Helix ¼ ð½hobs  100Þ=f½hhelix  ð1 2:57=lÞg ð1Þ
where [θ]obs is the mean-residue ellipticity observed experimentally at 222 nm,
[θ]helix is the ellipticity of a peptide of infinite length with 100% helix
population, taken as –39,500 deg·cm2dmol-1, and l is the peptide length or,
more precisely, the number of peptide bonds.3. Results
3.1. Four sets of peptides designed using HP(2–20)
HP(2–20) is a 19-residue amphipathic antimicrobial peptide,
with both hydrophilic and hydrophobic faces. In order to
correlate antimicrobial activity with the binding to and per-
meabilization of fungal and bacterial cell membranes, and to
determine the mode of action of the peptide, we designed four
sets of peptides using HP(2–20) as the parent peptide (Table 1).
In order to evaluate the influence of the N- and C-terminal amino
acids on the antimicrobial activity and the relationship between
the hydrophobic and hydrophilic regions of the peptide, we
designed a set of N- and C-terminal-deleted peptides. The im-
portance of hydrophobicity was evaluated using more hydro-
phobic peptides, in which one or more residues were substituted
with Trp. The effect of the addition of positive charges to the
peptide was then assessed via the substitution of one or more
residues with Lys or Arg. Finally, a fourth type of peptide was
designed, which harbored an especially high net charge. The
antimicrobial peptide, melittin, functioned as a control.
3.2. Antifungal, antibacterial, hemolytic activities and cell
viability of the peptides were assayed
Antifungal activity was assayed against representative
pathogenic yeast, which commonly infests immunocompro-
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are shown in Table 2. The data revealed that the peptides except
some peptide, including the parental HP(2–20), were active in
low-salt buffer (buffer I), and that the more hydrophobic
analogues HPA3, HPA3A1 and HPA3NT3 showed far more
profound activity against yeast than did HP(2–20).
HPA3, HPA3A1, and HPA3NT3 also showed profound
antimicrobial activity against Gram-positive (S. aureus) and
Gram-negative (E. coli) bacteria (Table 2), with MICs even
lower than those observed with C. albicans. This probably
reflects the fact that the bacterial membrane is more highly
negatively charged than is the zwitterionic yeast membrane. We
also tested the peptides via a hemolytic assay, using a highly
diluted (8%) hRBC suspension. Peptide hydrophobicity aug-
mented the hemolytic activity of the analogues, but with the
exception of HPA3A1, the peptides showed little or no
hemolytic activity at their MICs (Table 2). Potential lytic effects
were assessed via MTT assays in the culture media of peptide-
treated cells. The cell viability assay of the peptides designed in
this study against HaCaT cell lines was determined via MTT
assay. All tested peptides with the exception of HPA3A1 showed
little or no cytotoxic activity (Table 2). This suggests that HPA3
and HPA3NT3 peptides represent good candidates for the
development of novel antibiotic agents.
3.3. Antimicrobial peptides recognize chitin, peptidoglycan and
LPS in cell wall
We then assessed the capacity of HP(2–20) and melittin to
bind to various cell wall components, and determined that all ofTable 2
Antimicrobial and hemolytic activities of HP(2–20) and its analogues
Peptide designation MICs of peptide (μM)
C. albicans S. aureus
Buffer I Buffer II Buffer I Buffer II
HP 25 N200 6.25 N100
HPN1 100 N200 6.25 N100
HPN2 N100 N200 100 N100
HPN3 N100 N200 N100 N100
HPC1 25 N200 6.25 N100
HPC2 25 200 3.12 100
HPC3 50 N200 6.25 N100
HPN1C2 50 N200 6.25 N100
HPN1C3 100 N200 25 N100
HPN2C4 N100 N200 N100 N100
HPA1 25 100 3.12 25
HPA2 25 100 3.12 25
HPA3 6.25 25 0.78 6.25
HPA4 100 N200 25 N100
HPA5 N100 N200 50 N100
HPA3A1 6.25 25 0.78 3.12
HPA3NT0 25 100 6.25 50
HPA3NT1 25 50 3.12 25
HPA3NT2 25 50 1.56 12.5
HPA3NT3 12.5 12.5 0.78 3.12
HPC2A3 12.5 100 3.12 100
Melittin 3.12 6.25 0.78 1.56
a Hemolysis percentage at 100 μM of peptide in buffer II.
b Cytotoxicity at 25 μM of peptides.them bound specifically to chitin and peptidoglycan, but not to
chitosan, cellulose, or β-1,3-glucan (Fig. 1A and B). Thus, the
potency of a peptide's antimicrobial activity appears to be
associated with its binding affinity to chitin and peptidoglycan.
Consistent with that notion, the MICs of the peptides toward
microbial cells were similar to their binding affinities (Fig. 1C),
such that the highly active peptides, HPA3, HPA3NT3, and
melittin bound potently to chitin and peptidoglycan in both
buffer I and II and LPS in buffer I. In contrast, HPN3, HPN2C4,
HPA4, and HPA5 were practically inactive and showed no
binding to these cell wall components. We also compared the in
vivo effects of the peptides on Aspergillus flavus and Aspergillus
fumigatus, two fungi that do express chitin, and on Phy-
tophthora nicotinae and Phytophthora parasitica, two fungi that
do not express chitin (Table 3). We determined that HPA3,
HPA3NT3, and melittin showed highly potent antimicrobial
activity against the chitin-harboring fungi, but were inactive
against strains that did not harbor chitin. The other tested
peptides showed no antifungal activity.
3.4. Binding and permeabilization on various lipids
We utilized various lipids to determine the effects of the
antimicrobial peptides on the plasmamembranes of bacteria [30]
and RBCs [31]. One feature that distinguishes the membranes of
prokaryotic organisms from those of eukaryotic organisms is
that only the former harbor negatively charged lipids in the outer
leaflet of the plasma membrane [32]. We discovered that the
peptides associated readily with the PG and CL lipid possessing
negative charge in the bacterial membrane components (Fig. 2).Hemolysis a (%) Cytotoxicity b (%)
E. coli
Buffer I Buffer II
6.25 12.5 0 0
6.25 50 0 0
25 N100 0 0
N100 N100 0 0
6.25 12.5 0 0
3.12 6.25 0 0
6.25 N100 0 0
6.25 100 0 0
6.25 N100 0 0
N100 N100 0 3.24
3.12 12.5 0 0
3.12 12.5 0 0
1.56 3.12 23.11 15.14
6.25 100 0 4.12
6.25 100 0 3.25
3.12 6.25 94.69 100
6.25 12.5 4.70 0
3.12 6.25 9.65 0
3.12 6.25 14.92 11.38
0.78 3.12 11.62 8.76
3.12 6.25 4.5 13.20
0.78 0.78 100 100
Fig. 1. Binding activity of the synthetic peptides. In vitro binding assays were conducted using various cell wall components (A, B and C). The assayed peptides were
HP(2–20) (A) and melittin (B): lane 1, control; lane 2, chitin; lane 3, chitosan; lane 4, cellulose; lane 5, peptidoglycan; lane 6, β-1,3-glycan. (C) Binding of synthetic
peptides to chitin and peptidoglycan. The assay was conducted as in panels A and B, except that 10-μg samples of peptide were employed: a–d, Binding to chitin (a, b)
and peptidoglycan (c, d) in buffer I (a, c) and buffer II (b, d), respectively. e and f were performed against LPS with buffer I and buffer II. The assayed peptides were HP
(2–20) (lane 1), HPN3 (lane 2), HPC2 (lane 3), HPN2C4 (lane 4), HPA3 (lane 5), HPA4 (lane 6), HPA5 (lane 7), HPA3NT3(lane 8) and melittin (lane 9).
234 S.-C. Park et al. / Biochimica et Biophysica Acta 1778 (2008) 229–241Thus, the selective antibacterial activity of peptides is probably
exerted at the level of the charge on the anionic membrane
surface of these microorganisms. Distinctively, although the
HPA3NT3 had a strong antibacterial activity, it did not strongly
bind to PG.
The capacity of the peptides to permeabilize membranes was
assessed via measurements of the release of the fluorescent
marker calcein from liposomes with different lipid composi-
tions (Fig. 3). The activities of HPA3, HPA3NT3, and melittin
were most pronounced against liposomes composed of
zwitterionic PC, indicating an almost total disruption of these
vesicles at a concentration of 4 μM. At the same concentration,
HP(2–20) and HPN3 released 42% and 16% of the total
entrapped calcein respectively. In addition, sphingomyelin
exerted an appreciable effect on the permeabilizing activity of
HPA3, HPA3NT3, and melittin, which suggests that the cyto-Table 3
Antifungal activity against fungi with cell wall that do or do not contain chitin
Fungi MIC (μM)
HP(2–20) HPA3 HPA3NT3 Melittin
Aspergillus flavus 25 6 4 6
Aspergillus fumigatus 25 6 4 6
Phytophthora nicotinae N100 N100 N100 N100
Phytophthora parasitica N100 N100 N100 N100toxic activity of peptides against RBCs is associated with the
level of their hydrophobicity. However, we detected substantial
differences in the permeabilizing ability of the peptides against
liposomes comprised of cardiolipin (diphosphatidyl glycerol), a
unique four-tailed, doubly negatively-charged lipid phospho-
glyceride which is detected predominantly within the fungal
plasma membrane, and is believed to be a key determinant ofFig. 2. Binding assay of the synthetic peptides. In vitro binding assays were
conducted using various cell membrane components. Interaction between
synthetic peptides and liposomes composed of the indicated lipids were assayed.
1, HP(2–20); 2, HPN3; 3, HPA3; 4, HPA3NT3; 5, melittin.
Fig. 3. Peptide-induced release of calcein from liposomes. Calcein-containing liposomes composed of the indicated lipids were prepared and quantified as described in
Materials and methods. Liposome suspensions containing 100 μM lipids (♦:PC,▪: PG,▴: CL, and□: SM) were incubated with HP(2–20) (A), HPN3 (B), HPA3 (C),
HPA3NT3 (D), and melittin (E). The fluorescence of the released calcein was then assessed using a spectrofluorometer (excitation, 480 nm; emission, 520 nm). 100%
release was achieved using 1 mM Triton X-100.
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mined that melittin released approximately 32.69% of total
calcein at a concentration of 20 μM, whereas HPA3 and
HPA3NT3 exerted very little effect, which is consistent with
their respective activities against C. albicans (Table 2).
3.5. Peptide-induced membrane depolarization in bacteria,
bacterial spheroplasts, and yeast
In order to further determine the manner in which the
interaction of these peptides with the bacterial plasmamembrane
results in cell death, we evaluated the ability of the peptides to
induce membrane depolarization in both bacteria and bacterialspheroplasts (LPS and peptidoglycan-free bacteria). The pep-
tides were added to S. aureus ATCC 25923 (Fig. 4A),
spheroplasts of E. coli ATCC 25922 (Fig. 4B), intact E. coli
ATCC 25922 (Fig. 4C) orC. albicans (Fig. 4D) under conditions
similar to those previously reported [28]. Fig. 4 shows the dose-
dependent dissipation of the membrane potential by peptides,
which reveals there to be a direct correlation between the
peptide's antimicrobial activity and its ability to dissipate the
bacterial membrane potential. This suggests that the main target
of these peptides is the bacterial cytoplasmic membrane (inner
membrane). Of note is that once the cell wall (outer membrane)
is removed, HPA3, HPA3NT3 and melittin potently affect
membrane potential. In addition, HPA3 andHPA3NT3 showed a
Fig. 4. Peptide-induced depolarization of bacterial and fungal membranes (A, B, C and D). The indicated peptides were added to S. aureus (A), spheroplasts of E. coli
ATCC 25922 (B), intact E. coli ATCC 25922 (C), or C. albicans (D) that had been pre-equilibrated for 60 min with diS-C3-5. Fluorescence recovery was measured 1–
120min (at 5-min intervals) after the peptides (◆, HP(2–20);▪, HPA3;▴, HPN3;▵, HPA3NT3;□, HPC2A3;◇, melittin) had been mixed with the bacteria. Shown
are the maximum fluorescences.
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albicans than the other analogues, which is consistent with their
greater ability to induce calcein release.
3.6. The sizes of the different pores formed between peptides
In order to gather additional clues as to the type and extent of
membrane damage induced by HP(2–20) and its analogues, we
assessed the peptide-induced release of fluorescently labeled
dextran molecules of various sizes – i.e., FD4 (3.9 kDa, 1.8 nm
radii), FD10 (9.9 kDa), FD20 (19.8 kDa, 3.3 nm radii), FD40
(40.5 kDa, 4.8 nm radii), FD70 (71.6 kDa, 5 nm radii) and
FD500 (530 kDa). FD-entrapped liposomes were incubated with
10 μM of the peptides (peptide/lipid ratio=1/10) [33–35].
Assessing the differences in the sizes of the pores formed, one
may distinguish between peptides that function in a barrel-stave
manner or in a toroidal manner [36]. We determined that the
evoked release of FD varied inversely with its molecular mass/
size (Fig. 5A–D). For instance, HPA3, HPA3NT3 and melittin
released 100% of the FD4 from PC liposomes, but only 52% of
FD70. HP(2–20) released only 33% of the FD4 from PC
vesicles, and was unable to release any of the larger markers. The
pore created by HP(2–20) indicates that the radius is
approximately 1.8 nm and pores induced by HPA3, HPA3NT3
andmelittin have apparent radii between 3.3 and 4.8 nm at a 1/10
(peptide/lipid) molar ratio concentration.
When we compared the extents of release from liposomes
comprised of PC/cholesterol (Fig. 5B) or PE/PG (Fig. 5C), we
determined that release from the former was peptide-specific,whereas release from the latter did not vary among the peptides.
Finally, using liposomes composed of PC/cholesterol/sphingo-
myelin (hRBC, 1:1:1, w/w/w), we determined that the
introduction of Trp into peptides (HPA3, HPA3NT3 and
melittin) resulted in a dramatic increase in the extent of release,
which is consistent with the observed hemolytic activities of
those peptides (Table 2 and Fig. 5D).
3.7. HPA3, HPA3NT3 and Melittin oligomers generate ring-like
structures in transmission electron microscopy
In order to characterize the oligomeric states of the
membrane-bound peptides, we conducted chemical crosslinking
in the presence of liposomes. When bound to liposomes
composed of PC/cholesterol (1:1, w/w), HP(2–20) assumed a
uniquely dimeric form, whereas HPA3 formed more multimeric
complexes (∼8 mer, Fig. 6C).
We next employed transmission electron microscopy in order
to directly observe the formation of the peptide-induced pores. In
these experiments, liposome composed of PC/cholesterol or PE/
PG was incubated for 5 min with the indicated peptides. Fig. 6A
shows that HPA3, HPA3NT3, and melittin form ring-like
structures on the vesicles, which can be either attached to the
vesicle or released into the solution (panels 3–5). The pores
consisted of 7-to 8-nm-wide rings which encircled 3.5-to 4.5-
nm-wide cavities, and were formed by complexes (∼8 mer) of
HPA3, HPA3NT3, or melittin bound to the membranes. These
results were consistent with those of the FD-leakage assay and
cross-linking data in liposomes (Fig. 6C).
Fig. 5. The lipid compositions (A, PC; B, PC/CH (1:1); C, PE/PG (1:1); D, PC/CH/SM (1:1:1)) of the liposomes containing FD4, 10, 20, 40, 70, or 500 are indicated in
the text; they were prepared and quantified as described in Materials and methods. The release of dextran was fluorometrically determined. The apparent percentage of
release was calculated as 100×(F−F0) / (Ft−F0), in which F and Ft are the fluorescence intensities prior to and after the addition of the peptide (◆ HP(2–20);
▴, HPN3;▪, HPA3; ▵, HPA3NT3; □, HPC2A3;◇, melittin), respectively, and F0 is the fluorescence of the intact vesicles. Values are expressed as an average of
three independent measurements.
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observed using scanning electron microscopy
The effects of HP(2–20), HPA3, and HPA3NT3 on the
morphology of E. coli, S. aureus and C. albicans were
determined via scanning electron microscopy. When the
peptides were applied at concentrations corresponding to an
MIC of 60%, some differences were observed in the
morphology of the treated bacteria. HP(2–20) induced flab-
biness over the complete cell wall (Fig. 7A–C, panel 2),
whereas HPA3, HPA3NT3, and melittin induced local perturba-
tions and blebs (Fig. 7A–C, panels 3–5). This difference may
reflect the fact that HP(2–20) reaches the membrane predom-
inantly in the form of monomers that aggregate on the surfaces
of negatively-charged membranes once a threshold concentra-
tion has been reached [33], whereas HPA3, HPA3NT3, and
melittin reach the membrane as highly-ordered oligomers.
3.9. Structural analysis of peptides were observed using CD
Measurements in membrane mimicking environment
In order to investigate the relationship of the structure and the
antibiotic activity of the peptides on lipids, the CD spectra of the
peptides in phosphate buffer, SDS solution or PC/CH liposomewas measured. All peptides showed a random coil structure in an
aqueous solution, while displaying a typical α-helical spectrum
with two minimum peaks at 208 and 222 nm in 30 mM SDS or
PC/CH liposome solution (Fig. 8). HP(2–20), HPA3, HPA3NT3
formed α-helical structures except HPN3 in 30 mM SDS or PC/
CH liposome solution. HPA3 and HPA3NT3 have more potent
antibiotic activity in bacterial and fungal cells than HP (2–20),
while displaying higher α-helicity than HP (2–20) in liposome
(Fig. 8). These results suggest that the α-helical content in
liposomemay be correlated with the enhanced antibiotic activity
in killing bacterial and fungal cells.
4. Discussion
Linear antimicrobial peptides that assume an amphipathic α-
helical structure upon binding to bacterial membranes are
among the most abundant and widespread in nature. The
majority of cationic antimicrobial peptides possess bacteria cell-
selective activity, binding specifically to negatively-charged
phospholipids, which are the principal components of bacterial
cytoplasmic membranes [37,38], then permeabilizing the
membrane. They have substantially less affinity for zwitterionic
membranes, which mimic the membranes of fungi and other
eukaryotic cells. In our earlier study, we attempted to obtain
Fig. 6. Electron micrographs and cross-linking. Transmission electron micrographs showing the morphological changes in liposomes composed of PC/cholesterol
(1:1) (A) and PE/PG (1:1) (B). (A) Electron micrographs of PC/cholesterol liposomes in the absence (1) and presence of HP(2–20) (2), HPA3 (3), HPA3NT3 (4) or
Melittin (5). (B) Electron micrographs of PE/PG liposomes incubated with the same tested peptides. The insets show a highly ordered pore. Scale bar indicates 100 nm.
(C) The chemical cross-linking of peptides bound to liposomes composed of PC/CH (1:1, w/w): lane M, Marker; lane 1, HP(2–20); lane 2, HPA3.
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no cytotoxicity, and therefore designed novel peptide analogues
of HP(2–20) via the substitution of amino acids on the basis of
the peptide sequence and the effect on the α-helical wheel
diagram [39]. Such substitutions can alter the tertiary structureFig. 7. Scanning electron micrographs of C. albicans (A), E. coli (B), and S. aureus
panel 2, HP(2–20); panel 3, HPA3; panel 4, HPA3NT3; panel 5, melittin.of the HP(2–20) peptide, and may also confer potent antibiotic
activity [40].
In the present study, peptide sequences were altered using
four types of modification: (i) To determine the influence of
changes in the N- or C-terminal amino acids, and thus the(C) exposed to the indicated peptides at 60% MIC: panel 1, untreated peptide;
Fig. 8. CD spectra of HP (2–20) (A), HPN3 (B), HPA3 (C) and HPNT3 (D) in aqueous solution (▪), 30 mM SDS micelles (▴) and 1 mM PC/CH liposome (♦). The
concentration of peptides was 50 μM. CD spectra were recorded at 25 °C on a Jasco 810 spectropolarimeter (Jasco, MD, USA) equipped with a temperature control
unit. A 0.1-cm path-length quartz cell was used for CD analysis. At least five scans were averaged for each sample and the averaged blank spectra were subtracted.
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synthesized several peptides truncated from either the N- or C-
terminus. Antimicrobial activity against bacterial and fungal
cells was substantially attenuated via the removal of the N-
terminal amino acid residues of HP(2–20), which diminished
the amphipathicity of the peptide (Table 1 and 2) [41]. (ii)
Amino acids were substituted without altering the amphipathic
organization. The augmentation of the hydrophobicity of the
peptides via the substitution of Trp for Gln and Asp at positions
17 and 19 of HP(2–20) (HPA3) induced a dramatic increase in
selective antibacterial and antifungal activity, which suggests
that this peptide may facilitate not only the understanding of the
mechanism of action of the α-helical antibiotic peptides, but
also the design of novel antibiotics with enhanced antibiotic
activity. Interestingly, the substitution of Trp for all of the
hydrophobic amino acids – i.e., Ala, Gln and Asp at positions 2,
17 and 19 (HPA3A1) – increased the antimicrobial activity of
HP(2–20), but this analogue was also potently hemolytic and
cytotoxic (Table 2). Apparently, the tryptophan residue is a key
determinant of the hemolytic and cytotoxic properties of the
peptide. (iii) The addition of positive charges to the peptide via
the substitution of Lys for Ser and/or Glu (HPA3NT0-3) did not
significantly affect the peptides' potency or spectrum of activity,
but did make it increasingly less hemolytic and cytotoxic.
(iv) Deletion of the C-terminal and the addition of thepositively-charged Arg and Lys (HPC2A3) effected an increase
in the antimicrobial activity of HPC2, although it remained less
potent than that of HPA3.
We also determined that HP(2–20) and its analogues
specifically recognize common immune elicitors, including
chitin, peptidoglycan, and LPS (Table 3 and Fig. 1A–C).
Antimicrobial peptides must first be attracted to bacterial or
fungal surfaces, and one obvious mechanism by which this
may occur involves electrostatic bonding between anionic or
cationic peptides and structures on the surface. Previous studies
have demonstrated that peptides such as magainin 2 and
cecropin A can be readily inserted into monolayers, LUVs, and
liposomes harboring acidic phospholipids [42,43]. However,
Gram-negative and Gram-positive bacteria are far more
complex than model membranes, and cationic antimicrobial
peptides are likely to be attracted first to the net negative
charge existing on the outer envelope of Gram-negative
bacteria – e.g., the anionic phospholipids and phosphate
groups on LPS – and to the teichoic acids located on the
surface of Gram-positive bacteria. Artificial chimeric peptides,
such as CEME-related peptides, bind to both LPS and
lipoteichoic acid [44], but this binding is not associated with
their ability to kill bacteria, thereby suggesting that peptides
use this binding only to come into contact with other targets,
including the cytoplasmic membrane.
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the majority of its analogues were not hemolytic up to the
maximal tested concentrations (200 μM) (Table 2), despite the
fact that several of the more hydrophobic analogues also
permeate the zwitterionic membranes, although less efficiently
than the negatively-charged membranes (Fig. 2). Human RBCs
are rich in negatively-charged sialic acid-harboring carbohy-
drate moieties in the form of glycoproteins and glycosphingo-
lipids, which comprise the glycocalix layer. It is possible that the
peptides stick to the negatively-charged glycocalix layer and,
due to their limited capacity to partition within the zwitterionic
membranes [45], they cannot diffuse into the membrane. There
is also a general consensus that hydrophobic peptide–membrane
interactions may determine hemolytic potency [46], which is
correlated with the relatively high hydrophobicity and hydro-
phobic moments displayed by more hydrophobic HP(2–20)
analogues, including HPA3 and HA3A1. This increase in
hydrophobicity may compensate for the lack of amphipathic
structure.
The peptides were also evaluated with regard to their ability
to dissipate the membrane potential of intact S. aureus and
C. albicans, as well as the spheroplasts of two E. coli strains with
differing susceptibilities to the tested peptides (Fig. 4). We
determined there to be a direct correlation between the MICs of
the tested peptides toward S. aureus and C. albicans and their
ability to disrupt membrane potential (Fig. 4A). We determined
that all of the peptides showed similar activities toward the
spheroplasts (Fig. 4B), which indicates that the cytoplasmic
membrane is their target and that the differences in their
activities toward intact cells is reflective of their differing
abilities to diffuse through the outer membrane. Once across the
outer membrane, the peptides evidence similar abilities with
regard to the permeation of the cytoplasmic membrane.
We also determined that HP(2–20) and HPA3 strongly
interact with neutral zwitterionic lipid bilayers. This interaction
results in the perturbation of membrane integrity and the lysis of
lipid vesicles, as demonstrated by the release of fluorescent
markers (Fig. 5A–D). As was previously reported for temporins
A andB [47], the extent of the release was related inversely to the
size of the entrappedmarker, which is indicative of the formation
of pores or local breaks within the membrane, rather than
complete membrane disruption via a detergent-like action [48].
In addition, HPA3 reaches the cell membranes in oligomeric
form, where it forms toroidal pores, as was observed in the cross-
linking experiments (Fig. 6C) and transmission electron
micrographs, whereas HP(2–20) does not assume a highly-
ordered oligomeric form (Fig. 6A and B). The difference
between the morphology of the patches on the bacterial cell wall
observed with HPA3, HPA3NT3 and melittin (Fig. 7A–C) may
be related with their different oligomerization states upon
reaching the membrane.
Although the observations collected thus far do not allow us
to unequivocally elucidate the mechanism of action of HP(2–
20) and its analogues, the available data do suggest that an
appropriate balance of hydrophobic and electrostatic interac-
tions must regulate the interaction of these peptides with lipid
membranes in a complex manner, and thus modulate both theirtarget cell selectivity and biological properties. Further studies
are in progress to determine the membrane activity of HP(2–20)
and its analogues in greater detail.
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